Skip to content

Vital Signs Reduction Study

Minimizing Overnight Vital Signs to Improve Sleep in Hospitalized Children

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06865781
Enrollment
160
Registered
2025-03-10
Start date
2024-07-17
Completion date
2025-11-30
Last updated
2025-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hospitalization

Keywords

pediatric, hospitalization, vital signs, sleep

Brief summary

Overnight vital signs are typically done every four hours on pediatric acute care units, despite limited evidence supporting the efficacy of this practice. Additionally, vital signs are often ordered and collected without considering the patient's clinical status or the potential impact that they may have on sleep. The purpose of this study is to understand the effect of forgone overnight vital signs on sleep quality and duration among children hospitalized in medical-surgical units, compared with children who receive standard of care vital signs.

Detailed description

Patients will be screened at Primary Children's Hospital. Patients who are deemed eligible to forgo overnight vital signs will be considered for study. After written informed consent (parental permission/assent) is obtained, subjects who meet eligibility criteria will be allocated 1:1 to 2 treatment arms in sequential order: Group 1: standard of care vital signs monitoring and Group 2: no overnight vital signs at 0000 and 0400. The study period is approximately 24 hours, including one night of sleep. All participants will wear an actigraphy watch for one night and complete a sleep diary and sleep disruption survey after the study night. The primary endpoint is total sleep time, as measured by actigraphy. Secondary endpoints include nocturnal wake frequency, nocturnal wake duration (actigraphy), self-reported total sleep time (sleep diary), self-reported overnight disruptions (sleep diary), self-reported restfulness upon waking (sleep diary), self-reported sleep disturbances (sleep disturbance survey).

Interventions

OTHERForgone overnight vital signs

No vital signs (temp, heart rate, respiratory rate, blood pressure, oxygen saturation) taken at 0000 or 0400

Sponsors

Intermountain Health Care, Inc.
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Hospitalized at Primary Children's Hospital on units 3 Southeast, 3 Northeast, 3 Northwest * Age 1-18 years * Pediatric Early Warning Score ≤ 1 at 2000 * A parent/home caregiver present to consent to study * Patient and home caregiver speak English or Spanish. * Deemed appropriate for forgone overnight vital signs by care team (attending MD/Advanced Practice Provider and bedside RN).

Exclusion criteria

* Pre-existing diagnosis of hypertension, kidney disease, pulmonary hypertension, chronic lung disease, congenital heart disease causing cardiopulmonary compromise, obstructive sleep apnea, seizure disorder, neuromuscular disability. * Patients requiring O2 monitoring at home. * The following medications in the previous 24 hours: opioids, intravenous immunoglobulin, intravenous magnesium, continuous albuterol, benzodiazepines, other sedating medications beyond home regimen. * Anaphylaxis within 24 hours * Within the first 24 hours post-operative period * Requiring oxygen above baseline * Fever in the last 24 hours. * Sepsis alert in the last 72 hours.

Design outcomes

Primary

MeasureTime frameDescription
Total sleep timeFrom enrollment to end of treatment at 24 hoursMeasured by actigraphy

Secondary

MeasureTime frameDescription
Total sleep timeFrom enrollment to the end of treatment at 24 hoursBy self report via sleep diary
Overnight disruptionsFrom enrollment to the end of treatment at 24 hoursBy self report via sleep diary
Nocturnal wake frequencyFrom enrollment to the end of treatment at 24 hoursBy actigraphy
Nocturnal wake durationFrom enrollment to the end of treatment at 24 hoursBy actigraphy
Restfulness upon wakingFrom enrollment to the end of treatment at 24 hoursBy self report via sleep diary
Sleep disturbancesFrom enrollment to the end of treatment at 24 hoursBy self report via Patient-Reported Outcomes Measurement Information System (PROMIS) sleep disturbance survey

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026